Fragility Index Meta-Analysis of Randomized Controlled Trials Shows Highly Robust Evidential Strength for Benefit of  | Zendy

Katherine T Mun | Zendy; Jordan Bonomo | Zendy; David S. Liebeskind | Zendy; Jeffrey L. Saver | Zendy

Open Access

Fragility Index Meta-Analysis of Randomized Controlled Trials Shows Highly Robust Evidential Strength for Benefit of <3 Hour Intravenous Alteplase

Author(s) -

Katherine T Mun,

Jordan Bonomo,

David S. Liebeskind,

Jeffrey L. Saver

Publication year - 2022

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.121.038153

Subject(s) - medicine , randomized controlled trial , modified rankin scale , thrombolysis , stroke (engine) , meta analysis , fibrinolytic agent , tissue plasminogen activator , physical therapy , ischemic stroke , myocardial infarction , ischemia , mechanical engineering , engineering

Cumulative fragility index (FI) analysis enables quantification of the evidential strength of intravenous alteplase's core indication-treatment of disabling acute ischemic stroke within 3 hours of onset.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research